Blog
RSS FeedPosted by Michael Wonder on 25 Mar 2019
Canadian public places high priority on drugs’ safety, effectiveness, and certainty of evidence
25 March 2019 - Survey reveals top values for drug coverage decision making. ...
Posted by Michael Wonder on 21 Mar 2019
Why Ontario parents could soon be paying more for prescription drugs
22 March 2019 - Some Ontario parents will be paying more for their kids’ medicine starting next month. Young adults ...
Posted by Michael Wonder on 20 Mar 2019
Where is the champion for Pharmacare?
20 March 2019 - With the possible exception of a few drug company executives, Canadians overwhelmingly support universal pharmacare — ...
Posted by Michael Wonder on 20 Mar 2019
National drug agency touted as building block of Pharmacare plan
19 March 2019 - The Trudeau Liberals’ new budget promises a new agency to buy drugs in bulk and cut ...
Posted by Michael Wonder on 20 Mar 2019
Roche and the pan-Canadian Pharmaceutical Alliance complete negotiations for multiple sclerosis treatment, Ocrevus (ocrelizumab), for both RRMS and PPMS
19 March 2019 - Roche Canada today announced that it has completed negotiations with the pan-Canadian Pharmaceutical Alliance for a ...
Posted by Michael Wonder on 18 Mar 2019
The impact of pharmaceutical rebates on patients’ drug expenditures
18 March 2019 - The drug-pricing landscape in Canada is complex, with 4 different agencies and each provincial, territorial and federal ...
Posted by Michael Wonder on 14 Mar 2019
The Liberals’ plan for Pharmacare? We’re still waiting
14 March 2019 - The Trudeau government is edging closer to announcing its proposals for some kind of national drug ...
Posted by Michael Wonder on 11 Mar 2019
Trudeau Government signals it will soon announce Pharmacare plan
7 March 2019 - Morneau says drug program ‘unfinished business’ of health care. ...
Posted by Michael Wonder on 06 Mar 2019
Canada should create new drug agency and list of medications available to everyone, council says
6 March 2019 - Canada should tiptoe in the direction of national pharmacare by creating a new drug agency and ...
Posted by Michael Wonder on 06 Mar 2019
Patient advocacy groups in Canada with ties to pharma are big boosters for government coverage
5 March 2019 - As the interplay between the pharmaceutical industry and patient advocacy groups undergoes stepped-up scrutiny, a new ...
Posted by Michael Wonder on 28 Feb 2019
Drug prices aren’t a big problem, but Ottawa’s trying to control the market anyway
28 February 2019 - New policies will reduce access to new medicines for patients and impose massive new costs on taxpayers. ...
Posted by Michael Wonder on 27 Feb 2019
While some patients pay for biologic drugs, prison inmates get them for free
26 February 2019 - The Correctional Service of Canada spent more than $100 million over three-and-a-half years to provide inmates ...
Posted by Michael Wonder on 26 Feb 2019
Are low-priced drugs becoming an endangered species?
26 February 2019 - The price of Canada’s top-selling patented drugs has increased by 800 per cent over 10 years. ...
Posted by Michael Wonder on 21 Feb 2019
How big pharma donations may influence public drug coverage
21 February 2019 - A new review of 372 patient group submissions to the CADTH – about whether new medicines should ...
Posted by Michael Wonder on 21 Feb 2019
Canada finds "insufficient evidence" that Janssen blocked biosimilar competition
21 February 2019 - Despite the fact that the investigation confirmed many of the allegations against Janssen, the bureau concluded that, ...